CLINICAL TRIALS PROFILE FOR GOPRELTO
✉ Email this page to a colleague
All Clinical Trials for GOPRELTO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04792034 ↗ | Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution | Not yet recruiting | Pharmaceutical Project Solutions, Inc. | Phase 4 | 2021-04-01 | The purpose of this study is to assess the pharmacokinetic (PK) properties, safety, tolerability, and dosing of GOPRELTO® as an anesthetic for diagnostic procedures and surgeries on or through the mucous membranes of the nasal cavities in pediatric adolescent subjects. |
| NCT07287735 ↗ | Pharmacokinetics, Safety, and Tolerability of GOPRELTO and NUMBRINO in Pediatric Nasal Procedures | NOT_YET_RECRUITING | Omnivium Pharmaceuticals LLC | PHASE3 | 2025-12-06 | This open-label, two-arm, single-dose clinical study evaluates the pharmacokinetics, safety, and tolerability of GOPRELTO (cocaine hydrochloride nasal solution 4%) and NUMBRINO (cocaine hydrochloride nasal solution 4%) in pediatric subjects aged 12 to \ |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GOPRELTO
Condition Name
Clinical Trial Progress for GOPRELTO
Clinical Trial Phase
Clinical Trial Sponsors for GOPRELTO
Sponsor Name
